Peng Zhao

Peng Zhao


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2026 in Translational Oncology
Verified
Journal Article
Open access
SWSizhang Wang
Sizhang Wang
HWHua Qi Wang
Hua Qi Wang
HZHui Zhao
Hui Zhao
RZRuixia Zhao
Ruixia Zhao
PZPeng Zhao
Peng Zhao
QMQiang Mu
Qiang Mu
M2-like tumor-associated macrophages (TAMs), recognized as a significant risk factor in tumor progression, play a crucial role in the tumor microenvironment. While Sialic acid binding Ig like Lectin 15 (Siglec-15), an well-characterized immune-checkpoint inhibitor, has been demonstrated to impact immunotherapy response and tumor progression, its role in TMAs-mediated tumor progression remains largely unclear. In this study, we demonstrated that the high expression of Siglec-15 in triple-negative breast cancer (TNBC) acts as a pivotal driver of the interaction between tumor cells and macrophages. TNBC cells with overexpressed Siglec-15 can induce the polarization of macrophages into CC chemokine ligand 18 (CCL18)+ M2 macrophages and recruit macrophages. Furthermore, CCL18⁺ M2 TAMs can directly facilitate the malignant behaviors of TNBC cells. Mechanistically, they secrete CCL18, which promotes the expression of Siglec-15 via the phosphorylation of signal transducer and activator of transcription 3 (STAT3), thereby indirectly accelerating tumor progression. Molecular biochemical assays, including RNA sequencing on TNBC cells with overexpressed Siglec-15 and capillary reverse-phase liquid chromatography (LC)-tandem mass spectrometry (MS/MS) of the cell supernatant, demonstrated Siglec-15 upregulated the expression of Decoy receptor 3 (DcR3) in macrophages through Nuclear factor-kappa B (NF-κB) pathway. In summary, this study reveals a novel Siglec-15-mediated positive feed-forward loop between TNBC cells and macrophages, which relies on the NF-κB/DcR3/CCL18/STAT3 signaling axis to facilitate TNBC progression..